Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-13 · accession 0001735276-25-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-14 | 2025-03-13 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +2,750 | 11.2K | +33% | +$360.8K |
| D | 2025-03-14 | 2025-03-13 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $0.00 | -2,750 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-13 | M | A | 2,750 | $131.21 | 11,186 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-13 | M | D | 2,750 | $0.00 | 0 | D | $131.21 · 2016-06-01 to 2025-06-01 | 2,750 Common Stock | (F2) The stock option was fully vested as of June 1, 2016. |